FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA, VA to Test Health AI Tools

[ Price : $8.95]

FDA and the Veterans Administration say they are partnering to open a virtual laboratory to evaluate health-related artificial int...

PTC Therapeutics NDA Resubmission for Duchenne Drug

[ Price : $8.95]

FDA accepts for review a PTC Therapeutics NDA resubmission for Translarna (ataluren) and its use in treating nonsense mutation Duc...

Fast Track Status for Prolong Stroke Drug

[ Price : $8.95]

FDA grants Prolong Pharmaceuticals a fast-track designation for PP-007 (PEGylated carboxyhemoglobin, bovine) and its use for treat...

Organon/Shanghai Henlius Seek Biosimilar Approval

[ Price : $8.95]

FDA accepts for review a Shanghai Henlius Biotech and Organon BLA for their biosimilar of Amgens Prolia/Xgeva (denosumab).

CGMP Violations at Turkeys MedOffice Saglik

[ Price : $8.95]

FDA warns Turkeys MedOffice Saglik Endustri Anonim Sirketi about CGMP violations in its manufacturing of finished drugs.

8 Observations in Novo Nordisk FDA-483

[ Price : $8.95]

FDA releases a form FDA-483 with eight observations from an inspection at a Novo Nordisk drug substance manufacturing facility in ...

FDA Sets Acceptable NITMA Level for Ritonavir Products

[ Price : $8.95]

FDA publishes a guidance setting an acceptable intake level for NITMA, a nitrosamine drug substance-related impurity, in products ...

Grifols Vistaseal Gets Expanded Use in Pediatrics

[ Price : $8.95]

FDA approves a Grifols BLA supplement for its plasma-protein based fibrin sealant Vistaseal for controlling surgical bleeding in p...

Abeona Refiles BLA for Gene Therapy

[ Price : $8.95]

Abeona Therapeutics resubmits a BLA for prademagene zamikeracel (pz-cel), a gene therapy for patients with recessive dystrophic ep...

GE Healthcare EVair Recall Actions No Longer Apply: FDA

[ Price : $8.95]

FDA says GE Healthcare has determined there is no risk of elevated levels of formaldehyde from using its EVair compressor and rest...